HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 45649,
"recordsTotal": 45649,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&start=45000",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&start=44400",
"results": [
{
"registry_id": "NCT06997497",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06997497",
"title": "A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 Versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2029-08-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05485961",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05485961",
"title": "A Phase 2b / 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis",
"has_exemption": false,
"start_date": "2022-10-21",
"completion_date": "2029-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06837480",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06837480",
"title": "Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors With Chronic Lymphedema",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2029-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abramson Cancer Center at Penn Medicine",
"sponsor_slug": "abramson-cancer-center-at-penn-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03228667",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03228667",
"title": "QUILT-3.055: A Phase IIb, Multicohort, Open-Label Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors",
"has_exemption": false,
"start_date": "2018-12-11",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03737214",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03737214",
"title": "A Multi-center, Open-label, Uncontrolled, Single-arm, Extension Study to Determine the Long-term Safety and Tolerability of Oral Lucerastat in Adult Subjects With Fabry Disease",
"has_exemption": false,
"start_date": "2018-12-18",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Idorsia Pharmaceuticals Ltd.",
"sponsor_slug": "idorsia-pharmaceuticals-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05071300",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05071300",
"title": "An Open-Label, Extension Study to Assess the Long-Term Safety and Efficacy of ION-682884 in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy",
"has_exemption": false,
"start_date": "2022-01-04",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05307055",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05307055",
"title": "Theta Burst Subthalamic Nucleus Deep Brain Stimulation for Cognitive and Motor Improvements in Parkinson's Disease",
"has_exemption": false,
"start_date": "2022-01-11",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05461170",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05461170",
"title": "A Phase 2 Study to Evaluate Efficacy, Safety and Tolerability of VIR-2218 and VIR-3434 in Participants With Chronic Hepatitis D Virus Infection (SOLSTICE)",
"has_exemption": false,
"start_date": "2022-09-17",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vir Biotechnology, Inc.",
"sponsor_slug": "vir-biotechnology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05604131",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05604131",
"title": "Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients",
"has_exemption": false,
"start_date": "2022-11-08",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rohan Dharmakumar",
"sponsor_slug": "rohan-dharmakumar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05667493",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05667493",
"title": "An Open-Label Extension Study to Assess the Long-Term Safety of Eplontersen (ION-682884) in Patients With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)",
"has_exemption": false,
"start_date": "2022-11-30",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05496998",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05496998",
"title": "Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR Transfemoral System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial",
"has_exemption": false,
"start_date": "2023-02-07",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Cardiovascular",
"sponsor_slug": "medtronic-cardiovascular",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05777993",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05777993",
"title": "A Rollover Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored Mitapivat Study",
"has_exemption": false,
"start_date": "2023-07-06",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Agios Pharmaceuticals, Inc.",
"sponsor_slug": "agios-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06066580",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06066580",
"title": "An Open-Label Extension Study to Assess the Long-term Effect of EDG-5506 on Safety, Biomarkers, and Functional Measures in Adults and Adolescents With Becker Muscular Dystrophy",
"has_exemption": false,
"start_date": "2023-11-02",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Edgewise Therapeutics, Inc.",
"sponsor_slug": "edgewise-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06364280",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06364280",
"title": "Pediatric Prehospital Airway Resuscitation Trial",
"has_exemption": false,
"start_date": "2024-05-20",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06219174",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06219174",
"title": "Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06553872",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06553872",
"title": "A Phase 2, Open-Label, Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in Patients With Relapsed or Refractory Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-08-23",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06492616",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06492616",
"title": "Elacestrant Versus Standard Endocrine Therapy in Women and Men With Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer With High Risk of Recurrence-A Global, Multicenter, Randomized, Open-label Phase 3 Study",
"has_exemption": false,
"start_date": "2024-09-27",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stemline Therapeutics, Inc.",
"sponsor_slug": "stemline-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07050355",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07050355",
"title": "Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking (RESTORATION)",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06517212",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06517212",
"title": "Adjuvant Tirzepatide Plus Standard of Care Endocrine Therapy in Patients With Obesity or Overweight Who Have Hormone Receptor-positive, HER2-negative, Node-positive Early Breast Cancer, With Molecular Residual Disease (MRD), as Determined by Circulating Tumor DNA (ctDNA)",
"has_exemption": false,
"start_date": "2024-11-26",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor Research Institute",
"sponsor_slug": "baylor-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06517888",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06517888",
"title": "A Phase 1/2 Trial of AAVAnc80-antiVEGF Gene Therapy in Individuals With Unilateral Vestibular Schwannoma",
"has_exemption": false,
"start_date": "2025-01-17",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Akouos, Inc.",
"sponsor_slug": "akouos-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780137",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06780137",
"title": "A Phase 1b/2 Open-Label Clinical Study to Evaluate the Safety and Efficacy of MK-6070 and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788756",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06788756",
"title": "A Pivotal Phase 2/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of L Annamycin for Injection in Combination With Cytarabine Injection Versus Placebo in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2025-03-12",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Moleculin Biotech, Inc.",
"sponsor_slug": "moleculin-biotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06956300",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06956300",
"title": "Grit Against Cognitive Decline in Aging and Preclinical Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-04-07",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06811233",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06811233",
"title": "Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study",
"has_exemption": false,
"start_date": "2025-05-08",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06902558",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06902558",
"title": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of ABBV-CLS-628 in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07044635",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07044635",
"title": "Radiation Therapy in Reduced Dose and Hypofractionated Schedule After Trans-Oral Robotic Surgery in Intermediate Risk HPV-Mediated Oropharyngeal Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06629259",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06629259",
"title": "Guanfacine for Alcohol Use Disorder (AUD): a Telehealth Approach",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06625073",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06625073",
"title": "Randomized Trial of Sodium-glucose Cotransporter 2 Inhibition in Heart Transplant Recipients",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05422469",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05422469",
"title": "Neurobehavioral Investigations of Approach Dynamics in the Ventral Striatum",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06703216",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06703216",
"title": "Pilot Study of Pre-emptive Anakinra for the Prevention of Severe Cytokine Release Syndrome in Children and Young Adults With B-Acute Lymphoblastic Leukemia Receiving Chimeric Antigen Receptor (CAR) T Cells",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ann & Robert H Lurie Children's Hospital of Chicago",
"sponsor_slug": "ann-robert-h-lurie-childrens-hospital-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06790784",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06790784",
"title": "A Randomized Clinical Trial Evaluating Combination Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of Proliferative Diabetic Retinopathy",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaeb Center for Health Research",
"sponsor_slug": "jaeb-center-for-health-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06866964",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06866964",
"title": "A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06955169",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06955169",
"title": "MOMENTUM-1: A Multicenter, Randomized, Open-Label, Phase II Study of [177LU]LU-DOTATATE in Adults With Progressive Intracranial Grade 1-3 Meningioma",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "RTOG Foundation, Inc.",
"sponsor_slug": "rtog-foundation-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07086131",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07086131",
"title": "Impact Of Adding Inspiratory Muscle Training To Cardiac Rehabilitation On Exercise Responses In Heart Failure",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05963698",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05963698",
"title": "The Fourth Left Atrial Appendage Occlusion Study (LAAOS-4)",
"has_exemption": false,
"start_date": "2023-11-30",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hamilton Health Sciences Corporation",
"sponsor_slug": "hamilton-health-sciences-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06586021",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06586021",
"title": "SEAL - Safety & Feasibility Evaluation of the Aortoseal™ for Seal and Fixation of Abdominal Aortic Aneurysms (AAA) Endovascular Grafts to the Aortic Wall\"",
"has_exemption": false,
"start_date": "2024-02-06",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Endoron Medical",
"sponsor_slug": "endoron-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06722391",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06722391",
"title": "Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism",
"has_exemption": false,
"start_date": "2024-08-19",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas, El Paso",
"sponsor_slug": "university-of-texas-el-paso",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525740",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06525740",
"title": "Methadone Versus Intrathecal Hydromorphone for Postoperative Analgesia in Patients Undergoing Surgery for Gynecologic Malignancy Via Midline Laparotomy Receiving Liposomal Bupivacaine",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06580041",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06580041",
"title": "Precision Care for Major Depressive Disorder",
"has_exemption": false,
"start_date": "2024-11-12",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06483061",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06483061",
"title": "Ferumoxytol Enhanced Hippocampal Vascular Imaging in Epilepsy",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alberta",
"sponsor_slug": "university-of-alberta",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06949423",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06949423",
"title": "Accessing the Impact of Deep TMS Neuromodulation on Neural Circuits Associated With Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06645613",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06645613",
"title": "Precision TMS with Integrated Visualization and Analysis of Real-time E-field and EEG Source Imaging",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05827081",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05827081",
"title": "A Phase IIIb Study to Characterize the Efficacy and Safety of Adjuvant Ribociclib Plus Endocrine Therapy in a Close-to-clinical Practice Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER)",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06875310",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06875310",
"title": "A Randomized, Double-Blind, Phase 3 Trial of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)",
"has_exemption": false,
"start_date": "2025-04-24",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirati Therapeutics Inc.",
"sponsor_slug": "mirati-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03897881",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03897881",
"title": "A Phase 2 Randomized Study of Adjuvant Immunotherapy With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma (KEYNOTE- 942)",
"has_exemption": false,
"start_date": "2019-07-18",
"completion_date": "2029-09-09",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06686394",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06686394",
"title": "HERTHENA-Breast-01: A Phase 1b/2, Multicenter, Open-label, Dose-Finding Study to Evaluate the Safety and Antitumor Activity of Patritumab Deruxtecan in Participants With HER2 Positive Unresectable Locally Advanced Breast Cancer or Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2025-02-26",
"completion_date": "2029-09-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05135559",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05135559",
"title": "Open-label Study Investigating Efficacy, Safety and Pharmacokinetics of Concizumab Prophylaxis in Children Below 12 Years With Haemophilia A or B With or Without Inhibitors",
"has_exemption": false,
"start_date": "2022-03-24",
"completion_date": "2029-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04929028",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04929028",
"title": "Risk-Adapted Therapy for HIV-Associated Anal Cancer",
"has_exemption": false,
"start_date": "2022-08-09",
"completion_date": "2029-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05714202",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05714202",
"title": "A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-Risk Non-Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2023-03-23",
"completion_date": "2029-09-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04123795",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04123795",
"title": "Multicenter, Open Label or Double-Blind, Placebo-Controlled Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Pediatric Study Participants With Moderate to Severe Chronic Plaque Psoriasis",
"has_exemption": false,
"start_date": "2020-01-21",
"completion_date": "2029-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04794101",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04794101",
"title": "Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene",
"has_exemption": false,
"start_date": "2020-12-04",
"completion_date": "2029-09-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07024394",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07024394",
"title": "A Long-term Follow-up Study to Evaluate the Safety and Efficacy of Ruvometinib Tablets (FCN-159 Tablets) in Pediatric Participants With Neurofibromatosis Type 1",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2029-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.",
"sponsor_slug": "shanghai-fosun-pharmaceutical-industrial-development-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06324357",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06324357",
"title": "Beamion BCGC-1: A Phase Ib Dose Escalation and Phase II Dose Optimization, Randomized, Open-label, Multicenter Trial of Oral Zongertinib (BI 1810631) Alone or in Combination With Other Agents for the Treatment of Patients With Advanced HER2+ Metastatic Breast Cancer (mBC) and Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (mGEAC)",
"has_exemption": false,
"start_date": "2024-06-28",
"completion_date": "2029-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00781612",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00781612",
"title": "An Open-Label, Multicenter Extension Study of Trastuzumab Emtansine Administered as a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd-Sponsored Trastuzumab Emtansine Study",
"has_exemption": false,
"start_date": "2008-10-16",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03683251",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03683251",
"title": "A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Portal)",
"has_exemption": false,
"start_date": "2018-09-20",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05445323",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05445323",
"title": "A Phase 1/2 Study of the Safety and Efficacy of LX2006 Gene Therapy in Participants With Cardiomyopathy Associated With Friedreich's Ataxia",
"has_exemption": false,
"start_date": "2022-08-24",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lexeo Therapeutics",
"sponsor_slug": "lexeo-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05409989",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05409989",
"title": "MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study",
"has_exemption": false,
"start_date": "2022-09-20",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Microvention-Terumo, Inc.",
"sponsor_slug": "microvention-terumo-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05405361",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05405361",
"title": "A Long-term Extension of the ARGX-117-2002 Trial to Evaluate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy",
"has_exemption": false,
"start_date": "2023-01-18",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05467670",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05467670",
"title": "Safety and Efficacy of Anti-CD47, ALX148 in Combination with Liposomal Doxorubicin and Pembrolizumab in Patients with Recurrent Platinum-resistant Ovarian Cancer: Phase II Study",
"has_exemption": false,
"start_date": "2023-03-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexander B Olawaiye, MD",
"sponsor_slug": "alexander-b-olawaiye-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05526144",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05526144",
"title": "Low Dose Thyroid Hormone, Mitochondrial Fatty Acid Oxidation, and Treatment of Nonalcoholic Steatohepatitis (NASH)",
"has_exemption": false,
"start_date": "2023-04-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05891821",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05891821",
"title": "Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)",
"has_exemption": false,
"start_date": "2023-09-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immune Oncology Research Institute",
"sponsor_slug": "immune-oncology-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465745",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06465745",
"title": "AltaValve Pivotal Trial",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "4C Medical Technologies, Inc.",
"sponsor_slug": "4c-medical-technologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06528314",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06528314",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Compensated Cirrohosis Due to NASH/MASH",
"has_exemption": false,
"start_date": "2024-09-04",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akero Therapeutics, Inc",
"sponsor_slug": "akero-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06657859",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06657859",
"title": "A Phase 2, Open-Label Extension Study to Assess the Safety and Efficacy of GLM101 Administered Intravenously to Participants With PMM2-CDG",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Glycomine, Inc.",
"sponsor_slug": "glycomine-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07095205",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07095205",
"title": "Central Cholinergic Dysfunction in Depression: PET Imaging of a Novel Treatment Target With [18F]VAT to Assess the Antidepressant Effect of Nicotine",
"has_exemption": false,
"start_date": "2024-10-03",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06557512",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06557512",
"title": "A Pilot Trial of Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma (SRS-AIM)",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06526195",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06526195",
"title": "Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06359041",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06359041",
"title": "RESET-MG: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Participants With Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06406452",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06406452",
"title": "A Multi-Center Trial to Assess the Safety and Effectiveness of a Bioresorbable Tracheobronchial Splint in Pediatric Subjects With Clinically Significant Tracheobronchomalacia",
"has_exemption": false,
"start_date": "2025-01-07",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06493552",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06493552",
"title": "A Modular, Open Label, Randomized Phase II/III Trial to Assess Efficacy of Combining sEphB4-HSA (EphrinB2 Inhibitor) With Immunotherapy Regimens in Patients With EphrinB2-High Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-15",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vasgene Therapeutics, Inc",
"sponsor_slug": "vasgene-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06553885",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06553885",
"title": "A Phase II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic Colorectal Cancer or Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2025-03-24",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943872",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06943872",
"title": "A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2025-06-11",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011771",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07011771",
"title": "A Phase 1/2 Dose-Escalation Trial to Evaluate Safety, Tolerability, and Efficacy of a Single Dose of CAP-003 Gene Therapy Administered to Patients With Parkinson's Disease With GBA1 Gene Mutation (PD-GBA)",
"has_exemption": false,
"start_date": "2025-08-13",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Capsida Biotherapeutics, Inc.",
"sponsor_slug": "capsida-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06660225",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06660225",
"title": "Towards Closed Loop Deep Brain Stimulation for Treatment of Refractory Obsessive-Compulsive Disorder",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nader Pouratian",
"sponsor_slug": "nader-pouratian",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07088120",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07088120",
"title": "PRecision-Controlled Ventilation to Enhance Cardiac Arrest Intervention and Survival IN CPR: A Multi-Center Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06933706",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06933706",
"title": "Losartan to Improve Outcomes After Multi-ligament Knee Injury",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06274112",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06274112",
"title": "Personalized Neuromodulation Targeting Dysregulated Motivational Responses Underlying Social Avoidance Behavior",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Auburn University",
"sponsor_slug": "auburn-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465706",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06465706",
"title": "A Prospective, Multicenter, Randomized Controlled Trial Assessing the Safety and Efficacy of the LAmbre™ Plus Left Atrial Appendage Closure System to REDUCE the Risk of Thromboembolism in Patients With Non-Valvular Atrial Fibrillation",
"has_exemption": false,
"start_date": "2024-09-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Kansas City Heart Rhythm Research Foundation",
"sponsor_slug": "kansas-city-heart-rhythm-research-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06306638",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06306638",
"title": "A Phase I/II Study of Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients With Inoperable Malignant Central Airway Obstruction",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06548113",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06548113",
"title": "Investigation of Sensory Synchronized Human Brain Imaging and Neuromodulation",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06077071",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06077071",
"title": "MRIdian \"RADAR\" Trial - Radiosurgical Debulking of Asymptomatic/Radiographic Spinal Cord Compression Using Stereotactic MRI-guided Adaptive Radiotherapy",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05956821",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05956821",
"title": "Phase I/II Trial of Repeat Dosing of Super-Selective Intraarterial Infusion of Erbitux (Cetuximab) and Avastin (Bevacizumab) for Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06859099",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06859099",
"title": "Long-term Extension Study to Evaluate the Safety and Efficacy of Riliprubart (SAR445088) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2029-10-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06521567",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06521567",
"title": "Phase 1/2 Dose Determination and Dose Expansion Study of Cobolimab in Combination With Dostarlimab in Pediatric and Young Adult Participants With Newly Diagnosed and Relapsed/Refractory Tumors (POPSTAR)",
"has_exemption": false,
"start_date": "2025-03-06",
"completion_date": "2029-10-05",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06667726",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06667726",
"title": "A Centralized Protocol Evaluating the Safety and Clinical Impact of Amino Acid Pet for Brain Tumors",
"has_exemption": false,
"start_date": "2025-09-08",
"completion_date": "2029-10-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03552016",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03552016",
"title": "Evaluation of Progression of Myopia in Children Treated With Vitamin B2 and Outdoor Sunlight Exposure",
"has_exemption": false,
"start_date": "2018-10-10",
"completion_date": "2029-10-10",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06848088",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06848088",
"title": "Extended Follow-up of Patients With Melanoma Treated With Fianlimab Plus Cemiplimab in Expansion Cohorts From Study R3767-ONC-1613",
"has_exemption": false,
"start_date": "2025-04-14",
"completion_date": "2029-10-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979453",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06979453",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis",
"has_exemption": false,
"start_date": "2025-08-26",
"completion_date": "2029-10-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04908709",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04908709",
"title": "Spectroscopic MRI Guided Proton Therapy for Pediatric High-Grade Glioma (RAD4500)",
"has_exemption": false,
"start_date": "2018-12-20",
"completion_date": "2029-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06428409",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06428409",
"title": "A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers",
"has_exemption": false,
"start_date": "2024-06-20",
"completion_date": "2029-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04094090",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04094090",
"title": "Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia",
"has_exemption": false,
"start_date": "2019-10-19",
"completion_date": "2029-10-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Goodman Eye Center",
"sponsor_slug": "goodman-eye-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04708041",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04708041",
"title": "A Phase 3 International, Multicenter, Open-label Study to Evaluate the Safety and Immunogenicity of 9vHPV Vaccine Administered as 2-dose Regimen With Extended Dosing Intervals in 9- to 14-Year Old Boys and Girls Compared With a Standard 3-dose Regimen in 16- to 26-Year Old Women",
"has_exemption": false,
"start_date": "2021-03-15",
"completion_date": "2029-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04144972",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04144972",
"title": "Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain Using Summit RC+S",
"has_exemption": false,
"start_date": "2019-10-24",
"completion_date": "2029-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07000357",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07000357",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event",
"has_exemption": false,
"start_date": "2025-06-04",
"completion_date": "2029-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05933577",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05933577",
"title": "A Phase 3, Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With High-Risk Stage II-IV Melanoma (INTerpath-001)",
"has_exemption": false,
"start_date": "2023-07-19",
"completion_date": "2029-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05187338",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05187338",
"title": "Triplex CTLA4/PD1/PDL1 Checkpoint Inhibitors Combination Therapy for Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2021-11-01",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04743661",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04743661",
"title": "Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients With Recurrent Medulloblastoma and Ependymoma",
"has_exemption": false,
"start_date": "2022-04-04",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pediatric Brain Tumor Consortium",
"sponsor_slug": "pediatric-brain-tumor-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06513962",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06513962",
"title": "Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05097287",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05097287",
"title": "A Randomized, Double-Blind, Placebo Controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma",
"has_exemption": false,
"start_date": "2021-12-16",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05894343",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05894343",
"title": "Long-term Follow-up of Glutamic Acid Decarboxylase Gene Transfer to the Subthalamic Nuclei in Participants With Parkinson's Disease",
"has_exemption": false,
"start_date": "2023-05-19",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "MeiraGTx, LLC",
"sponsor_slug": "meiragtx-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05898620",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05898620",
"title": "A Phase 1/2, Open-Label Clinical Study to Evaluate Safety, Tolerability, and Efficacy of NGN-401 in Subjects With Rett Syndrome",
"has_exemption": false,
"start_date": "2023-06-13",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurogene Inc.",
"sponsor_slug": "neurogene-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05800743",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05800743",
"title": "Evaluation of the GORE® Ascending Stent Graft in the Treatment of Lesions of the Ascending Aorta",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649539",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06649539",
"title": "Efficacy of a Step-wise Protocol in Optimizing CCH Outcomes in Men With Peyronie's Disease",
"has_exemption": false,
"start_date": "2024-10-11",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Charitable Union for the Research and Education of Peyronie's Disease",
"sponsor_slug": "charitable-union-for-the-research-and-education-of-peyronies-disease",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06619561",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06619561",
"title": "A Phase 2, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, PK, and Efficacy of Vimseltinib in Adults With Active Chronic GVHD After Failure of Prior Systemic Therapy",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Deciphera Pharmaceuticals LLC",
"sponsor_slug": "deciphera-pharmaceuticals-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06558214",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06558214",
"title": "OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial",
"has_exemption": false,
"start_date": "2024-12-10",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06635889",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06635889",
"title": "Double-Blind Randomized Placebo Controlled Trial of Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06789445",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06789445",
"title": "A Phase 1/2a Study of Subretinal Administration of OpCT-001 Photoreceptor Precursor Cells Derived From iPSCs in Patients With Primary Photoreceptor Disease",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BlueRock Therapeutics",
"sponsor_slug": "bluerock-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06801834",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06801834",
"title": "A Global, Multicenter, Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Standard of Care (SOC) in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (ES-SCLC)",
"has_exemption": false,
"start_date": "2025-04-04",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06577714",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06577714",
"title": "Ablation Guided Via Precision Imaging Using Electromechanical Wave Imaging",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990867",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06990867",
"title": "Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Phase 2/3 Study to Evaluate the Efficacy and Safety of JX10 in Acute Ischemic Stroke With Late Presentations",
"has_exemption": false,
"start_date": "2025-05-15",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Corxel Pharmaceuticals",
"sponsor_slug": "corxel-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06418178",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06418178",
"title": "A Dose Optimization Study of MDMA-Assisted Therapy for PTSD in U.S. Veterans",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bronx VA Medical Center",
"sponsor_slug": "bronx-va-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06890338",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06890338",
"title": "A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects With FRα-Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06639282",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06639282",
"title": "SIPO1-AD: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Siponimod in Patients With Mild Alzheimer&Amp;#39;s Disease Dementia",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Joseph's Hospital and Medical Center, Phoenix",
"sponsor_slug": "st-josephs-hospital-and-medical-center-phoenix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06909565",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06909565",
"title": "Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06975111",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06975111",
"title": "Focusing on the Menopausal Transition to Improve Mid-Life Women's Health",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06718751",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06718751",
"title": "Tranexamic Acid Therapy For The Treatment of Subdural Hematomas",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07077395",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07077395",
"title": "Finding Links Between Hot flASHes and CardioVascular Disease",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06697496",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06697496",
"title": "Navigation and Artificial Intelligence Technology for Indigenous Virtual Education on Smoking Cessation (NAITIVE)",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03729817",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03729817",
"title": "VERiTAS-2 REFRESH ICAS (REstoring Flow by REvascularization with Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Case Western Reserve University",
"sponsor_slug": "case-western-reserve-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04865939",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04865939",
"title": "A Randomized Trial Comparing Intravesical Gemcitabine to Continuous Bladder Irrigation With Sterile Water to Prevent Bladder Cancer Implantation in Patients Undergoing Excision of Upper Tract Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2021-11-29",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05538663",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05538663",
"title": "A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE)",
"has_exemption": false,
"start_date": "2023-02-07",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854003",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06854003",
"title": "A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Christine Ryan",
"sponsor_slug": "christine-ryan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05707949",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05707949",
"title": "A Multicenter, Open-label, Extension Study to Evaluate the Long-term Safety and Tolerability of Atogepant in Pediatric Subjects 6 to 17 Years of Age With Migraine",
"has_exemption": false,
"start_date": "2023-06-05",
"completion_date": "2029-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06698003",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06698003",
"title": "A Phase 2 Study for Screening and Prevention of Adult T-cell Leukemia/Lymphoma With Mogamulizumab in High-Risk Carriers of HTLV-1",
"has_exemption": false,
"start_date": "2024-11-15",
"completion_date": "2029-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07052942",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07052942",
"title": "Individualizing Treatment for Asthma in Primary Care (Full Study)",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2029-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "DARTNet Institute",
"sponsor_slug": "dartnet-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05636618",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05636618",
"title": "A Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2023-09-27",
"completion_date": "2029-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Perspective Therapeutics",
"sponsor_slug": "perspective-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06134375",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06134375",
"title": "Novel Targeting of the Microenvironment to Decrease Metastatic Recurrence of High-Risk TNBC: A Randomized Phase II Study of Tetrathiomolybdate (TM) Plus Capecitabine in Patients With Breast Cancer at High Risk of Recurrence",
"has_exemption": false,
"start_date": "2024-11-26",
"completion_date": "2029-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Dartmouth-Hitchcock Medical Center",
"sponsor_slug": "dartmouth-hitchcock-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05526755",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05526755",
"title": "An Open-label, Single-arm, Phase II, Multinational, Multicentre Study to Assess the Efficacy and Safety of 5 Years of Osimertinib in Participants With EGFRm-positive Stage II-IIIB NSCLC, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy",
"has_exemption": false,
"start_date": "2023-03-06",
"completion_date": "2029-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06008756",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06008756",
"title": "Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk",
"has_exemption": false,
"start_date": "2023-10-09",
"completion_date": "2029-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03769766",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03769766",
"title": "A Randomized, Double-Blind, Placebo-Controlled Trial of Curcumin to Prevent Progression of Biopsy Proven, Low-risk Localized Prostate Cancer Patients Undergoing Active Surveillance",
"has_exemption": false,
"start_date": "2019-03-11",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05524883",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05524883",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study Assessing Safety, Tolerability, Pharmacodynamics, Efficacy, and Pharmacokinetics of DYNE-251 Administered to Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping",
"has_exemption": false,
"start_date": "2022-08-12",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dyne Therapeutics",
"sponsor_slug": "dyne-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03762395",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03762395",
"title": "Anti Inflammatory Lipid Mediators in Asthma: A Double Blind Placebo Control Cross Over, Proof of Concept Study of CXA-10 to Reduce Bronchial Hyperresponsiveness in Obese Asthmatics; Lipid Anti-Inflammatory Mediators in Asthma to Reduce Hyperresponsiveness in Obese Asthmatics",
"has_exemption": false,
"start_date": "2023-02-08",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05998031",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05998031",
"title": "A Mechanistic Study to Investigate tDCS and Working Memory in MCI Patients",
"has_exemption": false,
"start_date": "2024-04-24",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06399263",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06399263",
"title": "Study of Psilocybin for Anorexia in Young Adults",
"has_exemption": false,
"start_date": "2024-11-18",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Marissa Raymond-Flesch, MD, MPH",
"sponsor_slug": "marissa-raymond-flesch-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06609226",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06609226",
"title": "An Open-label, Multi-centre, Rollover Study to Characterise Long-term Safety and Efficacy of Etavopivat in Adults, Adolescents and Children Who Have Sickle Cell Disease or Thalassaemia and Have Completed a Treatment Period in an Etavopivat Study",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06589804",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06589804",
"title": "Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma With Platinum Refractory Disease",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06668493",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06668493",
"title": "A Phase 1/2, Single-arm, Open-Label Trial to Evaluate the Safety and Efficacy of Nadofaragene Firadenovec Instilled to the Renal Pelvis in Adult Subjects With Low-grade Upper Tract Urothelial Carcinoma (LG-UTUC)",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ferring Pharmaceuticals",
"sponsor_slug": "ferring-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07023289",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07023289",
"title": "A Phase 2, Randomized, Open-Label Study Comparing Telisotuzumab Adizutecan (ABBV-400) Monotherapy to the Current Standard of Care in Subjects With Post Adjuvant ctDNA Positive Colorectal Cancer and No Radiographic Evidence of Disease (NED)",
"has_exemption": false,
"start_date": "2025-09-05",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07095868",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07095868",
"title": "A Phase I/IIa Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of EVM14 as Monotherapy and in Combination With Pembrolizumab in Patients With Selected Solid Tumors",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Everest Medicines (Beijing) Co., Ltd.",
"sponsor_slug": "everest-medicines-beijing-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07069738",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07069738",
"title": "Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06660862",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06660862",
"title": "DAROSTEP: Evaluating Step Counts as a Biomarker and Its Relationship on Treatment Outcomes in Vulnerable Patients With Metastatic Hormone-Sensitive Prostate Cancer on Darolutamide and Androgen Deprivation Therapy",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07094542",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07094542",
"title": "Temporo-masseteric Nerve Block in Post-wisdom Tooth Extraction Pain- a Randomized Study",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01581580",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01581580",
"title": "Deep Brain Stimulation Surgery for Movement Disorders",
"has_exemption": false,
"start_date": "2011-08-17",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Neurological Disorders and Stroke (NINDS)",
"sponsor_slug": "national-institute-of-neurological-disorders-and-stroke-ninds",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04374305",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04374305",
"title": "Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)",
"has_exemption": false,
"start_date": "2020-06-20",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Scott R. Plotkin, MD, PhD",
"sponsor_slug": "scott-r-plotkin-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04532424",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04532424",
"title": "Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD",
"has_exemption": false,
"start_date": "2021-01-04",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04240054",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04240054",
"title": "A Multisite, Phase II Study of Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone (VICD) Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06447103",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06447103",
"title": "89Zr-DFO-GmAb PET/CT vs Contrast-Enhanced CT for Detection of Recurrent Clear Cell Renal Cell Carcinoma After Surgery",
"has_exemption": false,
"start_date": "2024-08-06",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04684212",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04684212",
"title": "Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF: The CORRAL-AF Study",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brian O'Neill MD",
"sponsor_slug": "brian-oneill-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096778",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07096778",
"title": "A Phase II, Open-Label, Multicenter Study of Inobrodib in Combination With Pomalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "CellCentric Ltd.",
"sponsor_slug": "cellcentric-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05130437",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05130437",
"title": "A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study",
"has_exemption": false,
"start_date": "2021-11-09",
"completion_date": "2029-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06449651",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06449651",
"title": "Double-blind, Randomized, Placebo-controlled Study Evaluating the Safety and Efficacy of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) in At-risk Pregnancies",
"has_exemption": false,
"start_date": "2024-11-11",
"completion_date": "2029-12-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06381154",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06381154",
"title": "Photodynamic Priming to Facilitate Immunologic Activity of Anti-PD1 in Patients With Pancreatic Cancer",
"has_exemption": false,
"start_date": "2024-12-06",
"completion_date": "2029-12-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06804642",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06804642",
"title": "Rehabilitation of Locomotor Function in Parkinson's Disease by Non-invasive Spinal Cord Stimulation",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2029-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064473",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07064473",
"title": "A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Type 2 Diabetes, Hypertension and Established Cardiovascular Disease",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2029-12-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04482933",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04482933",
"title": "Phase II Clinical Trial of HSV G207 With a Single 5 Gy Radiation Dose in Children With Recurrent High-Grade Glioma",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2029-12-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Pediatric Brain Tumor Consortium",
"sponsor_slug": "pediatric-brain-tumor-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06677060",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06677060",
"title": "A Phase III, Randomised, Placebo-controlled, Event-driven Study to Evaluate the Effect of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on the Risk of Incident Heart Failure and Cardiovascular Death",
"has_exemption": false,
"start_date": "2025-03-14",
"completion_date": "2029-12-17",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03684018",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03684018",
"title": "Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP",
"has_exemption": false,
"start_date": "2019-02-28",
"completion_date": "2029-12-20",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04684368",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04684368",
"title": "A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor",
"has_exemption": false,
"start_date": "2021-07-13",
"completion_date": "2029-12-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03904862",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03904862",
"title": "PBTC-053: A Pediatric Brain Tumor Consortium Phase I/ II and Surgical Study of CX-4945 in Patients With Recurrent SHH Medulloblastoma",
"has_exemption": false,
"start_date": "2019-07-25",
"completion_date": "2029-12-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Pediatric Brain Tumor Consortium",
"sponsor_slug": "pediatric-brain-tumor-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907147",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06907147",
"title": "Global Pilot Study of rEnal and Hepatic coMbINed denervatIon in Subjects With Uncontrolled Hypertension With and Without High Cardiovascular Risk",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2029-12-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Vascular",
"sponsor_slug": "medtronic-vascular",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05844982",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05844982",
"title": "A Trial Evaluating Intravitreal Faricimab (6.0 Mg) Injections or Fluocinolone Acetonide (0.19 Mg Intravitreal Implants Vs Observation for Prevention of Visual Acuity Loss Due to Radiation Retinopathy",
"has_exemption": false,
"start_date": "2023-11-21",
"completion_date": "2029-12-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaeb Center for Health Research",
"sponsor_slug": "jaeb-center-for-health-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05968326",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05968326",
"title": "A Phase II, Open-Label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Patients With Resected Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2023-10-18",
"completion_date": "2029-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05910801",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05910801",
"title": "Tafasitamab, Lenalidomide and Venetoclax Combination Therapy for Relapsed or Refractory Mantle Cell Lymphoma (V-MIND): a Phase II Study with Safety Lead-In",
"has_exemption": false,
"start_date": "2024-01-04",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Academic and Community Cancer Research United",
"sponsor_slug": "academic-and-community-cancer-research-united",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06764615",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06764615",
"title": "A Phase 2, Open-Label Extension Trial to Evaluate the Long-term Safety and Tolerability of Oral Zasocitinib (TAK-279) in Participants With Moderately to Severely Active Ulcerative Colitis and Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05569486",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05569486",
"title": "Elucidating the Central Mechanism(s) of Action for Green Light Therapy in Managing Chronic Pain",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01841723",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01841723",
"title": "A Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 (Ibrutinib) for Treatment of Relapsed Hairy Cell Leukemia",
"has_exemption": false,
"start_date": "2013-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02582697",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02582697",
"title": "Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours",
"has_exemption": false,
"start_date": "2014-02-28",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Sydney",
"sponsor_slug": "university-of-sydney",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03181867",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03181867",
"title": "18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer",
"has_exemption": false,
"start_date": "2017-08-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06984757",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06984757",
"title": "Mid-frontal Delta/Theta and Cognitive Control",
"has_exemption": false,
"start_date": "2017-09-25",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nandakumar Narayanan",
"sponsor_slug": "nandakumar-narayanan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03373968",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03373968",
"title": "Open Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT Studies",
"has_exemption": false,
"start_date": "2017-10-24",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Italfarmaco",
"sponsor_slug": "italfarmaco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03998527",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03998527",
"title": "Non-Invasive Spinal Cord Stimulation and Respiratory Plasticity",
"has_exemption": false,
"start_date": "2018-05-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03913559",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03913559",
"title": "Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2019-05-14",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03474029",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03474029",
"title": "Six Weeks of Daily Rifapentine vs. a Comparator Arm of 12-16 Week Rifamycin-based Treatment of Latent M. Tuberculosis Infection: Assessment of Safety, Tolerability and Effectiveness",
"has_exemption": false,
"start_date": "2019-08-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Centers for Disease Control and Prevention",
"sponsor_slug": "centers-for-disease-control-and-prevention",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03937635",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03937635",
"title": "Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)",
"has_exemption": false,
"start_date": "2019-09-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03911700",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03911700",
"title": "Prospective, Multi-Center, Open-Label, Randomized, Controlled Trial of Phasix™ Mesh to Prevent Incisional Hernia Subsequent to Open Midline Laparotomy",
"has_exemption": false,
"start_date": "2019-12-12",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "C. R. Bard",
"sponsor_slug": "c-r-bard",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04166318",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04166318",
"title": "A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)",
"has_exemption": false,
"start_date": "2020-01-02",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03971799",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03971799",
"title": "Phase 1/2 Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2020-01-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Center for International Blood and Marrow Transplant Research",
"sponsor_slug": "center-for-international-blood-and-marrow-transplant-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04609566",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04609566",
"title": "A Phase 2 Study of Brentuximab Vedotin in Combination With Pembrolizumab in Subjects With Metastatic Solid Malignancies",
"has_exemption": false,
"start_date": "2021-01-26",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Seagen, a wholly owned subsidiary of Pfizer",
"sponsor_slug": "seagen-a-wholly-owned-subsidiary-of-pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04746677",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04746677",
"title": "Single-Center Investigational Device Exemption Trial: Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)",
"has_exemption": false,
"start_date": "2021-03-15",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04474847",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04474847",
"title": "A Randomized Double-Blind, Placebo Controlled Trial of Abatacept (CTLA4-Ig) in Giant Cell Arteritis (ABAGART)",
"has_exemption": false,
"start_date": "2021-03-29",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05269004",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05269004",
"title": "A Multicenter, Single-Arm, Open-Label, Extension, Rollover Study To Evaluate The Long-Term Safety And Efficacy Of Ocrelizumab In Patients With Multiple Sclerosis",
"has_exemption": false,
"start_date": "2022-05-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05183646",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05183646",
"title": "A Pivotal Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of DMX-200 in Patients With Focal Segmental Glomerulosclerosis (FSGS) Who Are Receiving an Angiotensin II Receptor Blocker (ARB)",
"has_exemption": false,
"start_date": "2022-05-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dimerix Bioscience Pty Ltd",
"sponsor_slug": "dimerix-bioscience-pty-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06946264",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06946264",
"title": "Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic Features",
"has_exemption": false,
"start_date": "2022-07-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nemours Children's Clinic",
"sponsor_slug": "nemours-childrens-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05409066",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05409066",
"title": "A Phase 3, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination With Rituximab and Lenalidomide (R2) Compared to R2 in Subjects With Relapsed or Refractory Follicular Lymphoma (EPCORE FL-1)",
"has_exemption": false,
"start_date": "2022-09-20",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05527340",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05527340",
"title": "Multicenter, Phase II, National and Open-label Study to Evaluate Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.",
"has_exemption": false,
"start_date": "2022-09-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "PETHEMA Foundation",
"sponsor_slug": "pethema-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05776069",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05776069",
"title": "A Multi-Modular Trial to Evaluate VGA039 in Healthy Volunteers and Patients with Von Willebrand Disease and Other Bleeding Disorders (VIVID)",
"has_exemption": false,
"start_date": "2023-03-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vega Therapeutics, Inc",
"sponsor_slug": "vega-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05616546",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05616546",
"title": "Longitudinal Analysis of Bone Marrow and Peripheral Blood Immune Responses to Influenza Vaccination in a Healthy Adult Cohort",
"has_exemption": false,
"start_date": "2023-10-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06126380",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06126380",
"title": "AT-1501-K209: BESTOW-EXTENSION: A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2023-10-25",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eledon Pharmaceuticals",
"sponsor_slug": "eledon-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05977751",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05977751",
"title": "FINALE: Prospective Multi-Center Trial for FemBloc INtratubal Occlusion for TranscervicAL PErmanent Birth Control",
"has_exemption": false,
"start_date": "2023-10-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Femasys Inc.",
"sponsor_slug": "femasys-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06105749",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06105749",
"title": "Outcome of Biennial Screening Contrast-Enhanced Mammography (CEM) in Women with a Personal History of Breast Cancer (PHBC)",
"has_exemption": false,
"start_date": "2023-11-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wendie Berg",
"sponsor_slug": "wendie-berg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06238648",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06238648",
"title": "Multicenter, Randomized Phase II Study of Epcoritamab for Patients With Aggressive B-Cell Lymphomas Achieving a Partial Response After CD19-Directed CAR-T Therapy",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Academic and Community Cancer Research United",
"sponsor_slug": "academic-and-community-cancer-research-united",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06264609",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06264609",
"title": "Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover - Follow Up Study",
"has_exemption": false,
"start_date": "2024-02-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul F Netzel",
"sponsor_slug": "paul-f-netzel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06164275",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06164275",
"title": "A Phase II Multi-Center Open-Label Trial of Six Doses of Pembrolizumab Monotherapy Prior to Limited Chemotherapy as Front-Line Therapy for Patients With Classical Hodgkin Lymphoma, Including Elderly Patients.",
"has_exemption": false,
"start_date": "2024-02-06",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06227949",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06227949",
"title": "FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients: an Exploratory Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ellen Greenblatt",
"sponsor_slug": "ellen-greenblatt",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06292208",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06292208",
"title": "Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) and Preliminary Efficacy of IBD0333 in Patients With Locally Advanced/Metastatic Solid Tumor or Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2024-03-09",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SUNHO（China）BioPharmaceutical CO., Ltd.",
"sponsor_slug": "sunhochinabiopharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06216470",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06216470",
"title": "Phase II Investigator-Initiated Study to Understand the Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University Health Network, Toronto",
"sponsor_slug": "university-health-network-toronto",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06172296",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06172296",
"title": "A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2024-04-19",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06964152",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06964152",
"title": "Prospective Use of Computational Cardiac Imaging Analysis to Guide Ventricular Tachycardia Ablation Procedures (AI-VT)",
"has_exemption": false,
"start_date": "2024-05-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06200103",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06200103",
"title": "Minority-Inclusive Imaging Biomarker-Based End of Therapy Trial for 177Lu-PSMA-617, a Randomized De-Escalation Theranostic Trial for Metastatic Castrate Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2024-05-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06395402",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06395402",
"title": "177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry",
"has_exemption": false,
"start_date": "2024-05-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Iowa",
"sponsor_slug": "university-of-iowa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06207799",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06207799",
"title": "Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-07-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06526338",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06526338",
"title": "A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of IP-001 as Adjuvant Therapy in Participants With Hepatocellular Carcinoma After Complete Radiological Response After Surgical Resection and Local Ablation or Local Ablation Alone",
"has_exemption": false,
"start_date": "2024-07-24",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Robert C. Martin",
"sponsor_slug": "robert-c-martin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06107764",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06107764",
"title": "Cerebellar Modulation of Cognition in Psychosis",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mclean Hospital",
"sponsor_slug": "mclean-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445946",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06445946",
"title": "DECIDE: A Comparative Effectiveness Trial of Oral Metformin Versus Injectable Insulin for the Treatment of Gestational Diabetes",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06061809",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06061809",
"title": "Open-label Phase 2 Study of N-803 and PD-L1 t-haNK Combined With Bevacizumab in Subjects With Recurrent or Progressive Glioblastoma",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06518551",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06518551",
"title": "A Phase I/II Study of Elotuzumab and Iberdomide and Dexamethasone Post Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Omar Nadeem, MD",
"sponsor_slug": "omar-nadeem-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06575192",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06575192",
"title": "A Prospective, Multicenter, Open-Label, Non-Randomized, Controlled Pivotal Study to Evaluate the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix in Implant-Based Two Stage Prepectoral Breast Reconstruction Post-Mastectomy",
"has_exemption": false,
"start_date": "2024-11-05",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06500975",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06500975",
"title": "Long Term Outcomes After Vestibular Implantation",
"has_exemption": false,
"start_date": "2024-12-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06735976",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06735976",
"title": "Efficacy & Safety of LOBO™ Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations (PAVM)",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06711705",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06711705",
"title": "Phase II MRD-Adapted Study of Elranatamab in Relapsed/Refractory",
"has_exemption": false,
"start_date": "2024-12-18",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05213676",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05213676",
"title": "Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia (CDH) - The \"NoNO Trial\" - a Multi-center, De-implementation, Stepped-wedge, Cluster-randomized Trial Within an Established Collaborative",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06132178",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06132178",
"title": "Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06769633",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06769633",
"title": "A Phase 2 Open-label (Core Phase Plus Extension Phase) With 2 Cohorts Study to Assess the Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Than 6 Years Old",
"has_exemption": false,
"start_date": "2025-01-02",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Italfarmaco",
"sponsor_slug": "italfarmaco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06712316",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06712316",
"title": "A Phase II/III, Multisite, Randomized Master Protocol for a Global Trial of BNT327 in Combination With Chemotherapy and Other Investigational Agents in First-line Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-01-07",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05669846",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05669846",
"title": "Phase II Feasibility Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06030037",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06030037",
"title": "Randomized Phase II Study of Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/Refractory (R/R) Melanoma",
"has_exemption": false,
"start_date": "2025-03-11",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06797635",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06797635",
"title": "An Open-label Randomized Phase 2 Study to Evaluate Safety and Efficacy of Patritumab Deruxtecan Plus Pembrolizumab Administered Either Before or After Carboplatin/Paclitaxel Plus Pembrolizumab Compared With Pembrolizumab in Combination With Chemotherapy Followed by Surgery and Adjuvant Pembrolizumab for High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer (HERTHENA-Breast03)",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06765109",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06765109",
"title": "A Phase 3 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 Compared to Alectinib in First-Line Treatment of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (ALKAZAR)",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nuvalent Inc.",
"sponsor_slug": "nuvalent-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05766839",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05766839",
"title": "A 2-Part, Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children Under 12 Years of Age With Hyperkalaemia (EMERALD2)",
"has_exemption": false,
"start_date": "2025-04-06",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vifor Pharma, Inc.",
"sponsor_slug": "vifor-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06736171",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06736171",
"title": "Prescription of Robotic Exoskeletons for Ambulation Recovery Post Stroke",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kessler Foundation",
"sponsor_slug": "kessler-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064018",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07064018",
"title": "Phase Ib/IIa Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Irvine",
"sponsor_slug": "university-of-california-irvine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07003425",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07003425",
"title": "A Long-term Extension Study to Evaluate the Safety and Efficacy of APG777 in Patients With Atopic Dermatitis Previously Treated With APG777",
"has_exemption": false,
"start_date": "2025-05-14",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Apogee Therapeutics, Inc.",
"sponsor_slug": "apogee-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06901531",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06901531",
"title": "A Phase 3, Double-blind, Randomized Study of Zolbetuximab in Combination With Pembrolizumab and Chemotherapy (CAPOX or mFOLFOX6) in First-line Treatment of Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma in Participants Whose Tumors Are HER2-negative, Claudin (CLDN) 18.2-positive and Programmed Death-ligand 1 (PD-L1)-Positive",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06561074",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06561074",
"title": "A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06508931",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06508931",
"title": "A Single-arm, Multi-center, Open-label Phase II Study to Determine the Safety and Efficacy of MB-CART2019.1 in Pediatric Subjects With Relapsed/Refractory (r/r) Mature B-cell Neoplasms Who Have Relapsed After One or More Prior Therapies, Including Subjects With Primary Refractory Disease",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Miltenyi Biomedicine GmbH",
"sponsor_slug": "miltenyi-biomedicine-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06740968",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06740968",
"title": "Improving Neural Oscillation and Synchrony Between Motor and Auditory Regions in Stuttering Using Personalized Transcranial Alternating Current Stimulation (tACS)",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06681220",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06681220",
"title": "Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC",
"has_exemption": false,
"start_date": "2025-08-20",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07060638",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07060638",
"title": "Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Samer Gawrieh",
"sponsor_slug": "samer-gawrieh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854029",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06854029",
"title": "Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02864888",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02864888",
"title": "A Controlled, Study of the Effect of Combination Antineoplaston Therapy [Atengenal (A10) and Astugenal (AS2-1)] on the QT/QTc Interval In Subjects With Newly Diagnosed Diffuse, Intrinsic, Brainstem Glioma",
"has_exemption": false,
"start_date": "2027-06-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Burzynski Research Institute",
"sponsor_slug": "burzynski-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04337515",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04337515",
"title": "A Feasibility Study of Using the CiniMacs® Device for Alpha/Best T-Cell Depletion in Stem Cell Transplant Recipients",
"has_exemption": false,
"start_date": "2019-12-19",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Christopher Dvorak",
"sponsor_slug": "christopher-dvorak",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05088798",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05088798",
"title": "Use of18F-DOPA PET/MRI for the Detection and Localization of Focal Forms of Hyperinsulinism",
"has_exemption": false,
"start_date": "2020-09-10",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06034821",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06034821",
"title": "Rapid Reversal of Suicidal Depression: Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD)",
"has_exemption": false,
"start_date": "2023-10-01",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02773082",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02773082",
"title": "Reclaim™ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD)",
"has_exemption": false,
"start_date": "2024-07-06",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06068543",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06068543",
"title": "A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07010146",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07010146",
"title": "Role of Estrogen Formulation and Route of Delivery on Skeletal Outcomes in Functional Hypothalmic Amenorrhea",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07043972",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07043972",
"title": "Phase II Study of Second-line Gemcitabine Plus Carboplatin After Progression on Enfortumab Vedotin With Pembrolizumab in Advanced or Metastatic Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fox Chase Cancer Center",
"sponsor_slug": "fox-chase-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06303193",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06303193",
"title": "Phase I/II Trial of Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06440707",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06440707",
"title": "Transcranial Electrical Stimulation in Stroke EaRly After Onset Clinical Trial 2",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06214793",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06214793",
"title": "A Phase II Study of Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) of the Breast (TaCe)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Megan Kruse, MD",
"sponsor_slug": "megan-kruse-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06987539",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06987539",
"title": "A Phase 2 Open-label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children From 2 Years to Less Than 18 Years of Age With Generalized Myasthenia Gravis (gMG)",
"has_exemption": false,
"start_date": "2025-08-29",
"completion_date": "2030-01-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06670105",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06670105",
"title": "A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell Lymphoma",
"has_exemption": false,
"start_date": "2025-06-06",
"completion_date": "2030-01-06",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05454306",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05454306",
"title": "The Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures; A U.S. Prospective Case Series",
"has_exemption": false,
"start_date": "2028-01-09",
"completion_date": "2030-01-09",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00109174",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00109174",
"title": "MRS (Magnetic Resonance Spectroscopy) Measurement of Glutamate and GABA Metabolism in Brain",
"has_exemption": false,
"start_date": "2006-09-06",
"completion_date": "2030-01-11",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Mental Health (NIMH)",
"sponsor_slug": "national-institute-of-mental-health-nimh",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05800015",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05800015",
"title": "A Randomized, Double-Blind Phase 2/3 Study of Fianlimab (Anti-LAG-3 Antibody), Cemiplimab (Anti-PD-1 Antibody), and Chemotherapy Versus Cemiplimab and Chemotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Irrespective of PD-L1 Expression Levels",
"has_exemption": false,
"start_date": "2023-08-08",
"completion_date": "2030-01-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01687608",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01687608",
"title": "A Phase 1/2 Open-Label, Single Ascending Dose Trial of a Self-Complementing Optimized Adeno-associated Virus Serotype 8 Factor IX Gene Therapy (AskBio009) in Adults With Hemophilia B",
"has_exemption": false,
"start_date": "2013-02-11",
"completion_date": "2030-01-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Baxalta now part of Shire",
"sponsor_slug": "baxalta-now-part-of-shire",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06868277",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06868277",
"title": "A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab Monotherapy for the First-line Treatment of Patients With PD-L1-high Metastatic Non-small Cell Lung Cancer (ARTEMIDE-Lung04)",
"has_exemption": false,
"start_date": "2025-04-10",
"completion_date": "2030-01-17",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04638647",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04638647",
"title": "An Open-label, Multi-center Protocol for Patients Who Have Completed a Previous Novartis Sponsored Secukinumab Study and Are Judged by the Investigator to Benefit From Continued Secukinumab Treatment",
"has_exemption": false,
"start_date": "2020-12-22",
"completion_date": "2030-01-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06909825",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06909825",
"title": "A Phase 2, Open-label, Multi-centre Study of FPI-2265 (225Ac-PSMA-I&T) and Olaparib in Participants With Metastatic Castration Resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2025-02-26",
"completion_date": "2030-01-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Fusion Pharmaceuticals Inc.",
"sponsor_slug": "fusion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04008368",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04008368",
"title": "Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease or Beta-Thalassemia and Falling Donor Myeloid Chimerism Levels",
"has_exemption": false,
"start_date": "2019-10-24",
"completion_date": "2030-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06205485",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06205485",
"title": "A Phase 3 Randomized Trial Of Neoadjuvant Chemotherapy, Excision And Observation Versus Chemoradiotherapy For Early Rectal Cancer",
"has_exemption": false,
"start_date": "2024-06-26",
"completion_date": "2030-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Cancer Trials Group",
"sponsor_slug": "canadian-cancer-trials-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00785525",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00785525",
"title": "Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors",
"has_exemption": false,
"start_date": "1997-02-28",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Center for International Blood and Marrow Transplant Research",
"sponsor_slug": "center-for-international-blood-and-marrow-transplant-research",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01538056",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01538056",
"title": "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysm: an Investigator Initiated Study",
"has_exemption": false,
"start_date": "2011-03-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03599752",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03599752",
"title": "The Role of Multimodality Management in Risk-Stratified Patients With Lung-Limited Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2018-07-02",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03801083",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03801083",
"title": "A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Locally Advanced, Recurrent, or Metastatic Biliary Tract Cancers",
"has_exemption": false,
"start_date": "2019-02-19",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Udai Kammula",
"sponsor_slug": "udai-kammula",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04375722",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04375722",
"title": "Exogenous Tuning of Neural Oscillations as a Mode of Treatment in Post-stroke Aphasia",
"has_exemption": false,
"start_date": "2020-01-04",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05030441",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05030441",
"title": "A Pilot Study of Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1",
"has_exemption": false,
"start_date": "2022-04-01",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05554302",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05554302",
"title": "Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis",
"has_exemption": false,
"start_date": "2023-01-10",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05643742",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05643742",
"title": "A Phase 1/2, Open-Label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD19 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX112) in Subjects With Relapsed or Refractory B Cell Malignancies",
"has_exemption": false,
"start_date": "2023-03-10",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CRISPR Therapeutics AG",
"sponsor_slug": "crispr-therapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06193551",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06193551",
"title": "Ovitex in Paraesophageal and Large Hiatal Hernia Repair. (OviPHeR)",
"has_exemption": false,
"start_date": "2024-02-19",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Foregut Research Foundation",
"sponsor_slug": "foregut-research-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06412666",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06412666",
"title": "A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled and Open-Label Extension Trial to Evaluate the Efficacy and Safety of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy",
"has_exemption": false,
"start_date": "2024-05-29",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cytokinetics",
"sponsor_slug": "cytokinetics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06559176",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06559176",
"title": "A Phase 1/2 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Modified Ex Vivo Using Prime Editing (PM359) in Participants With Autosomal Recessive Chronic Granulomatous Disease Due to Mutations in the NCF1 Gene",
"has_exemption": false,
"start_date": "2024-10-17",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prime Medicine, Inc.",
"sponsor_slug": "prime-medicine-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06857773",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06857773",
"title": "Hepatic Arterial Infusion PUMP Chemotherapy Combined With Systemic Therapy Versus Systemic Therapy Alone as Induction Therapy for Initially Unresectable Colorectal Liver Metastases: a Randomised Controlled Trial",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Netherlands Cancer Institute",
"sponsor_slug": "the-netherlands-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06581406",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06581406",
"title": "A Randomized, Phase 2/3, Open-Label Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab Versus Ipilimumab in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Replimune Inc.",
"sponsor_slug": "replimune-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06200259",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06200259",
"title": "Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Thompson Cancer Survival Center",
"sponsor_slug": "thompson-cancer-survival-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06607406",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06607406",
"title": "A Randomized Trial of Accelerated Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC (Head and Neck Squamous Cell Carcinoma) Initiating Radiotherapy Greater Than 6 Weeks After Surgery (PORTRush)",
"has_exemption": false,
"start_date": "2025-01-21",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06745882",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06745882",
"title": "Prospective Trial to Assess Real-world Outcomes and Predictive Biomarkers of Response to Pembrolizumab With or Without Chemotherapy in Black Patients With NSCLC",
"has_exemption": false,
"start_date": "2025-01-21",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06781931",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06781931",
"title": "DG1 Spectacle Lens for Myopia Progression Control in Children: A Three-year Multicenter, Prospective, Randomized, Double-masked, Controlled Clinical Trial to Evaluate the Efficacy and Safety Followed by a One-year Rebound Evaluation",
"has_exemption": false,
"start_date": "2025-01-21",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "HOYA Lens Thailand LTD.",
"sponsor_slug": "hoya-lens-thailand-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06842355",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06842355",
"title": "A Multicenter, Phase 2, Dose-Escalation/Dose-Expansion Study of TYRA-300 in Children With Achondroplasia With Open Growth Plates: BEACH301",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tyra Biosciences, Inc",
"sponsor_slug": "tyra-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06717438",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06717438",
"title": "A Phase 2 Randomized, Double-blind, Placebo-controlled, Study of Zatolmilast (BPN14770) in Subjects With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome)",
"has_exemption": false,
"start_date": "2025-05-13",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shionogi",
"sponsor_slug": "shionogi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07076225",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07076225",
"title": "A Ultrashort Regimen for Drug-susceptible Pulmonary Tuberculosis in Elderly Patients: A Multicenter Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-07-25",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shenzhen Third People's Hospital",
"sponsor_slug": "shenzhen-third-peoples-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04756063",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04756063",
"title": "Parenteral Ascorbic Acid Repletion in TransplantatIon (PARTI): A Randomized, Double-Blinded, Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06977438",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06977438",
"title": "Promoting Healthy Children and Youth",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01754363",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01754363",
"title": "Short, Medium and Long Term Survivorship of Attune Primary Knee Prosthesis",
"has_exemption": false,
"start_date": "2013-02-01",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "DePuy International",
"sponsor_slug": "depuy-international",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04130997",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04130997",
"title": "An Open Label Extension Study of Ublituximab in Subjects With Relapsing Multiple Sclerosis",
"has_exemption": false,
"start_date": "2019-11-18",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "TG Therapeutics, Inc.",
"sponsor_slug": "tg-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06934239",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06934239",
"title": "Evaluating the Impact of Artificial Intelligence on Breast Cancer Screening Quality and Effectiveness: A Prospective Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06413680",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06413680",
"title": "A Phase 1/2a, Open-Label, Dose-Escalation and Dose-Expansion First-In-Human Study of the Safety, Tolerability, Activity, and Pharmacokinetics of REGN10597 (Anti PD-1-IL2RA-IL2 Fusion Protein) in Patients With Advanced Solid Organ Malignancies",
"has_exemption": false,
"start_date": "2024-09-23",
"completion_date": "2030-02-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03309332",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03309332",
"title": "OSB Lead-AMPLATZER PFO Occluder New Enrollment PAS",
"has_exemption": false,
"start_date": "2018-01-31",
"completion_date": "2030-02-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04528082",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04528082",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study, Followed by an Active Treatment Phase to Evaluate the Efficacy and Safety of Apremilast in Children From 2 to Less Than 18 Years of Age With Active Oral Ulcers Associated With Behçet's Disease (BEAN)",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2030-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04980872",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04980872",
"title": "A Multicenter, Open-label, Phase 2, Extension Trial to Study the Long-term Safety in Participants With PROS or Proteus Syndrome Who Are Currently Being Treated With Miransertib in Other Studies",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2030-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06799390",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06799390",
"title": "Vagus Nerve Stimulation Following Intracerebral Hemorrhage (IHC) to Mitigate ICH-induced Inflammation and Cerebral Edema",
"has_exemption": false,
"start_date": "2025-04-06",
"completion_date": "2030-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06846281",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06846281",
"title": "A Randomized, Open-label, Parallel-group, Non-inferiority Study Comparing Efficacy, Safety, and Tolerability of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis, Followed by Open-label Treatment With Remibrutinib",
"has_exemption": false,
"start_date": "2025-06-16",
"completion_date": "2030-02-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06863272",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06863272",
"title": "MK-2400-01A Substudy: A Phase 1/2, Open-label Umbrella Substudy of MK-2400-U01 Master Protocol to Evaluate the Safety and Efficacy of Ifinatamab Deruxtecan-based Treatment Combinations or Ifinatamab Deruxtecan Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (IDeate-Prostate02)",
"has_exemption": false,
"start_date": "2025-07-03",
"completion_date": "2030-02-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07000149",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07000149",
"title": "A Phase Ib/III Randomized, Multicenter, Global Study of Volrustomig Plus Casdatifan or Volrustomig Monotherapy Versus Nivolumab Plus Ipilimumab as First-line Treatment for Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)",
"has_exemption": false,
"start_date": "2025-07-08",
"completion_date": "2030-02-21",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04104776",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04104776",
"title": "A Phase 1/2 Study of DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas",
"has_exemption": false,
"start_date": "2019-09-18",
"completion_date": "2030-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00338377",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00338377",
"title": "Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma",
"has_exemption": false,
"start_date": "2006-02-01",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01966367",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01966367",
"title": "CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplantation for Non-Malignant Disease",
"has_exemption": false,
"start_date": "2013-03-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Diane George",
"sponsor_slug": "diane-george",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02912312",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02912312",
"title": "Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): A Randomized Trial of Hypofractionated Versus Conventionally Fractionated Regional Nodal Irradiation for Invasive Breast Cancer",
"has_exemption": false,
"start_date": "2017-02-23",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03726554",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03726554",
"title": "Comprehensive Reverse Shoulder: Porous Augmented Glenoid Baseplate and Mini Humeral Tray Post-Market Clinical Follow-up Study",
"has_exemption": false,
"start_date": "2018-08-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04408352",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04408352",
"title": "Selective Bladder Denervation Using RF Energy for the Treatment of UUI",
"has_exemption": false,
"start_date": "2020-04-27",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hologic, Inc.",
"sponsor_slug": "hologic-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04174105",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04174105",
"title": "A Phase 1/2, Open-Label, Ascending-Dose Clinical Study to Evaluate the Safety and Preliminary Efficacy of AT845, an AAV8-Delivered Gene Transfer Therapy in Patients With Late Onset Pompe Disease",
"has_exemption": false,
"start_date": "2020-10-27",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Gene Therapies",
"sponsor_slug": "astellas-gene-therapies",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06433635",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06433635",
"title": "Sequential Multiple Assignment Randomized Trial for Bipolar Depression",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06895785",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06895785",
"title": "Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-02-21",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06839976",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06839976",
"title": "CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Adolescents and Young Adults With Systemic Lupus Erythematosus (SLE)",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06915233",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06915233",
"title": "A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients With Symptomatic Chondral or Osteochondral Lesions of the Talus (MASCOT)",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Vericel Corporation",
"sponsor_slug": "vericel-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06625190",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06625190",
"title": "Allogeneic Stem Cell Transplantation Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion With Zoledronic Acid in Combination to Treat Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06919666",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06919666",
"title": "Phase Ib/II Study of NT219 in Combination With Pembrolizumab or Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07003997",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07003997",
"title": "Janus Kinase (JAK) Signaling in Depression",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06824649",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06824649",
"title": "SMART Use of Biologics in Chronic Rhinosinusitis With Nasal Polyposis",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06871488",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06871488",
"title": "Identification of Neural Markers of Aggression and Irritability and Their Capacity to Predict Treatment Response to CNS Stimulant Medication in Youth With ADHD",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}